Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
Publication
, Conference
Peters, KB; Vredenburgh, JJ; Desjardins, A; Friedman, HS; Herndon, JE; Coan, AD; McSherry, F; Lipp, ES; Brickhouse, A; Massey, WC; Reardon, DA
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2012
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2012
Volume
30
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Vredenburgh, J. J., Desjardins, A., Friedman, H. S., Herndon, J. E., Coan, A. D., … Reardon, D. A. (2012). Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
Peters, Katherine B., James J. Vredenburgh, Annick Desjardins, Henry S. Friedman, James Emmett Herndon, April D. Coan, Frances McSherry, et al. “Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Herndon JE, Coan AD, et al. Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.
Peters, Katherine B., et al. “Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 15, AMER SOC CLINICAL ONCOLOGY, 2012.
Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Herndon JE, Coan AD, McSherry F, Lipp ES, Brickhouse A, Massey WC, Reardon DA. Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2012
Volume
30
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences